PHARMAGILLY
ActiveDeeds, filings and financial milestones
2025
25-09
full format · 56 days late
2024
30-08
micro format · 30 days late
2023
31-12
Financial
Highest result from 2018 to 2024net €33,610 ▲24.3%
The operating result of €53,594 and the net result of €33,610 are both a record.
31-12
Financial
Equity above €200,000equity €215,307 ▲18.5%
After 5 profitable years in a row, equity reaches €215,307.
30-08
micro format · 30 days late
16-08
micro format · 381 days late
22-06
Bankruptcy
Judicial dissolution, liquidator appointed
Enterprise Court of Hainaut, Charleroi division · Schreder Philippe-Robert · judgment of 19-06-2023
2021
31-12
Financial
Equity above €150,000equity €154,661 ▲16%
After 3 profitable years in a row, equity reaches €154,661.
22-11
micro format · 114 days late
2020
30-11
micro format · 122 days late
2019
31-12
Financial
Back to profitnet €14,200
The net result is €14,200, after one loss-making year.
31-12
Financial
Equity above €100,000equity €108,274 ▲15.1%
Equity rises from €94,075 to €108,274.
Show earlier events
28-10
micro format · 89 days late
2018
28-09
micro format · 59 days late
2017
20-07
micro format · 11 days before the deadline
2016
01-07
full format · 30 days before the deadline
2003
28-07
SignalFinancial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank